CSI Market
Sign In | Register

Acumen Pharmaceuticals Inc (ABOS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ABOS Annual Balance Sheets →
Quarterly balance sheet trends provide context on Acumen Pharmaceuticals Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ABOS/balance-sheets
https://api.csimarket.com/api/v1/companies/ABOS/fundamentals
https://api.csimarket.com/api/v1/companies/ABOS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent53.08
Restricted Cash0.23
Marketable Securities, Current SH25.53
Cash & Short-term Investments78.00
Other Receivables1.75
Prepaid Expense And Other Assets Current0.00
Total Current Assets85.13
Equipment/Property/Plant Net0.07
Long-term investments0.00
Deferred Costs, Noncurrent AS6.73
Other Assets, Noncurrent0.00
Restricted Cash Noncurrent0.23
Total Assets85.57
Liabilities
Accounts Payable, Current AC6.06
Accrued Liabilities, Current AC10.17
Short-term Debt DE120.40
Other Liabilities, Current8.46
Total Current Liabilities45.09
Long-term debt5.87
Total Long-term Debt5.87
Combined Long+Short Total Debt (filer-reported)26.27
Other liabilities, Noncurrent0.00
Accrued Clinical Trial Expenses Current8.18
Total Liabilities50.96
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock559.91
Retained Earnings / Accumulated Deficit-525.29
Accumulated Other Comprehensive Income-0.03
Other Equity-0.03
Common Stockholder's Equity34.61
Total Stockholder's Equity34.61
Liabilities & Stockholder's Equity85.57
4 historic quarters locked

Sign in to unlock the full Acumen Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Acumen Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-067276

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI